Print this page

Department of Psychiatry Faculty

Photo: Kirk J. Brower, M.D., FASAM

Kirk J. Brower, M.D., FASAM

Contact Information


Primary Programs/Services:
Substance Abuse


  • 1981-85, Residency in Psychiatry, UCLA
  • 1977-81, M.D. degree, UC Irvine
  • 1973-76, B. A. degree, UCLA

Clinical Interest:

  • Addiction Psychiatry

Research Interest:

  • Alcoholism and Sleep
  • Addiction Pharmacotherapy
  • Predictors of Treatment Outcome for Alcohol Dependence
  • Anabolic Steroid Dependence

Academic Appointment:

  • Professor of Psychiatry, Medical School
  • Director, Addiction Psychiatry Training Program
  • Executive Director, UM Addiction Treatment Services

Recent or Representative Publications:

  • Brower KJ, Kim HM, Strobbe S, Karam-Hage MA, Consens F, Zucker RA. A randomized double-blind pilot trial of gabapentin vs. placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res, 2008: 32(8):1429-1438. (PMC2927959)
  • Wojnar M, Brower KJ, Strobbe S, Ilgen M, Matsumoto H, Nowosad I, Sliwerska E, Burmeister M. Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res 2009; 33:693-702. (PMC2928673)
  • Brower KJ: Anabolic steroid abuse and dependence in clinical practice. Physician Sportsmed 2009; 37:131-140.
  • Brower KJ, McCammon RJ, Wojnar M, Ilgen MA, Wojnar J, Valenstein M. Prescription sleeping pills, insomnia, and suicidality in the National Comorbidity Survey Replication. J Clin Psychiatry 2010 (DOI: 10.4088/JCP.09m05484gry)

Curriculum Vitae: